Latest Breaking News On - Institute of behavioral science - Page 13 : comparemela.com

Pill to Counter Postpartum Depression Looks Good in Trial, May Gain FDA Approval

WEDNESDAY, Aug. 2, 2023 (HealthDay News) All eyes are on the U.S. Food and Drug Administration this week as the agency weighs approval of a new pill that may

New yorkUnited statesEl caminoNirmaljit dhamiLos angelesKristina deligiannidisSahar mcmahonInstitute of behavioral scienceDrug administrationEl camino health in mountain viewUniversity of californiaFeinstein institutes for medical research in manhassetHealthday newsBehavioral scienceFeinstein institutesMedical research

FDA weighs approval of pill to treat postpartum depression

All eyes are on the U.S. Food and Drug Administration this week as the agency weighs approval of a new pill that may quickly treat and ease severe postpartum depression.

United statesEl caminoNew yorkNirmaljit dhamiKristina deligiannidisSahar mcmahonLos angelesUniversity of californiaInstitute of behavioral scienceDrug administrationEl camino health in mountain viewAmerican college of obstetriciansFeinstein institutes for medical research in manhassetBehavioral scienceFeinstein institutesMedical research

Postpartum depression pill showing positive results in trials

A first-of-its-kind pill for postpartum depression had promising results in recent trials, and could be approved as soon as next week. Zuranolone is now being evaluated by the Food and Drug Administration, and a decision is expected on Aug. 5.

United statesKristinam deligiannidisKristina deligiannidisDrug administrationWomen behavioral health at zucker hillside hospitalInstitute of behavioral scienceNational institute of healthAmerican journalFeinstein institutesMedical researchBehavioral healthZucker hillsideBehavioral scienceSage therapeuticsKarches family distinguished chairNational institute

Postpartum depression pill safe & effective: Study

A pill used for postpartum depression (PPD) is safe for use and has shown to be effective in managing symptoms, results of a new study has shown.PPD is a common perinatal complication experienced by one in eight women and has adverse maternal .

New yorkUnited statesKristinam deligiannidisInstitute of behavioral scienceDrug administrationSage therapeuticsAmerican journalBehavioral scienceFeinstein institutesPriority review

Novel pill could aid postpartum depression symptoms

Novel pill could aid postpartum depression symptoms
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United statesKristinam deligiannidisJournal of the american medical associationDrug administrationInstitute of behavioral scienceBehavioral scienceFeinstein institutesAmerican journalAmerican medical association